Indications and Purposes
| 1 Indications And Usage Tivicay Is Indicated In Combination With: • Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Adults And In Pediatric Patients Weighing At Least 30 Kg [See Microbiology ( 12.4 )] . • Rilpivirine As A Complete Regimen For The Treatment Of Hiv-1 Infection In Adults To Replace The Current Antiretroviral Regimen In Those Who Are Virologically Suppressed (Hiv-1 Rna Less Than 50 Copies Per Ml) On A Stable Antiretroviral Regimen For At Least 6 Months With No History Of Treatment Failure Or Known Substitutions Associated With Resistance To Either Antiretroviral Agent. Tivicay Is A Human Immunodeficiency Virus Type 1 (Hiv-1) Integrase Strand Transfer Inhibitor (Insti) Indicated In Combination With: • Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection In Adults And In Pediatric Patients Weighing At Least 30 Kg. ( 1 ) • Rilpivirine As A Complete Regimen For The Treatment Of Hiv-1 Infection In Adults To Replace The Current Antiretroviral Regimen In Those Who Are Virologically Suppressed (Hiv-1 Rna Less Than 50 Copies Per Ml) On A Stable Antiretroviral Regimen For At Least 6 Months With No History Of Treatment Failure Or Known Substitutions Associated With Resistance To Either Antiretroviral Agent. ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Dolutegravir Sodium |
|
ZINC58581064 |